Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-2.65%
Change (1 year)
Categories
Rigel Pharmaceuticals (RIGL) - Total assets
Total assets on the balance sheet as of December 2023 : $0.11 B
According to Rigel Pharmaceuticals's latest financial reports the company's total assets are $0.11 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Rigel Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -12.7% |
| 2022-12-31 | $0.13 B | -19.75% |
| 2021-12-31 | $0.16 B | 51.6% |
| 2020-12-31 | $0.11 B | -25.2% |
| 2019-12-31 | $0.14 B | 6.08% |
| 2018-12-31 | $0.13 B | 16.79% |
| 2017-12-31 | $0.11 B | 52.44% |
| 2016-12-31 | $78.13 M | -40.69% |
| 2015-12-31 | $0.13 B | -14.52% |
| 2014-12-31 | $0.15 B | -31.82% |
| 2013-12-31 | $0.22 B | -27.09% |
| 2012-12-31 | $0.31 B | 20.59% |
| 2011-12-31 | $0.25 B | 37.71% |
| 2010-12-31 | $0.18 B | 32.65% |
| 2009-12-31 | $0.14 B | -2.16% |
| 2008-12-31 | $0.14 B | 24.24% |
| 2007-12-31 | $0.11 B | 2.25% |
| 2006-12-31 | $0.11 B | -23.31% |
| 2005-12-31 | $0.14 B | 87.34% |
| 2004-12-31 | $78.82 M | 41.96% |
| 2003-12-31 | $55.52 M | 25.22% |
| 2002-12-31 | $44.34 M | -4.53% |
| 2001-12-31 | $46.44 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $97.15 B | 82,778.23% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 87,162.10% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $0.16 B | 41.03% | 🇺🇸 USA |
 ChemoCentryx CCXI | N/A | N/A | 🇺🇸 USA |